Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GTLB, CRWD, DXCM, ARM, FRSH, and represent 62.12% of Alphabet's stock portfolio.
- Added to shares of these 4 stocks: GTLB (+$415M), FRSH (+$151M), PRME (+$22M), Fractyl Health.
- Started 1 new stock position in Fractyl Health.
- Reduced shares in these 7 stocks: DXCM (-$262M), CRWD (-$137M), OSCR (-$17M), NMRA (-$6.9M), IVVD (-$5.1M), VERA, Science 37 Holdings.
- Sold out of its positions in NMRA, Science 37 Holdings.
- Alphabet was a net buyer of stock by $161M.
- Alphabet has $2.5B in assets under management (AUM), dropping by 16.55%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 43 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Gitlab Class A Com (GTLB) | 22.6 | $569M | +268% | 9.8M | 58.32 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 10.9 | $274M | -33% | 856k | 320.59 |
|
| Dex (DXCM) | 9.9 | $248M | -51% | 1.8M | 138.70 |
|
| Arm Holdings Sponsored Adr (ARM) | 9.7 | $245M | 2.0M | 124.99 |
|
|
| Freshworks Class A Com (FRSH) | 8.9 | $225M | +205% | 12M | 18.21 |
|
| Revolution Medicines (RVMD) | 6.8 | $171M | 5.3M | 32.23 |
|
|
| Verve Therapeutics (VERV) | 6.5 | $164M | 12M | 13.28 |
|
|
| Uipath Cl A (PATH) | 6.3 | $160M | 7.0M | 22.67 |
|
|
| Prime Medicine (PRME) | 4.2 | $105M | +26% | 15M | 7.00 |
|
| Snowflake Cl A (SNOW) | 3.4 | $87M | 536k | 161.60 |
|
|
| Planet Labs Pbc Com Cl A (PL) | 3.2 | $82M | 32M | 2.55 |
|
|
| Sana Biotechnology (SANA) | 1.1 | $28M | 2.8M | 10.00 |
|
|
| Adagio Therapeutics (IVVD) | 0.8 | $20M | -20% | 4.5M | 4.44 |
|
| Lyell Immunopharma (LYEL) | 0.5 | $13M | 5.9M | 2.23 |
|
|
| Relay Therapeutics (RLAY) | 0.5 | $13M | 1.6M | 8.30 |
|
|
| Beam Therapeutics (BEAM) | 0.4 | $11M | 322k | 33.04 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.4 | $10M | -20% | 241k | 43.12 |
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $10M | 1.5M | 7.05 |
|
|
| Desktop Metal Com Cl A (DM) | 0.4 | $9.7M | 11M | 0.88 |
|
|
| Tscan Therapeutics (TCRX) | 0.3 | $8.6M | 1.1M | 7.94 |
|
|
| Illumina (ILMN) | 0.3 | $7.3M | 54k | 137.32 |
|
|
| Oscar Health Cl A (OSCR) | 0.3 | $7.2M | -70% | 482k | 14.87 |
|
| Dianthus Therapeutics (DNTH) | 0.2 | $6.3M | 209k | 30.00 |
|
|
| Fractyl Health | 0.2 | $4.9M | NEW | 663k | 7.40 |
|
| Rapt Therapeutics (RAPT) | 0.2 | $4.9M | 540k | 8.98 |
|
|
| Tenaya Therapeutics (TNYA) | 0.2 | $4.8M | 916k | 5.23 |
|
|
| Autolus Therapeutics Spon Adr (AUTL) | 0.2 | $4.5M | 698k | 6.38 |
|
|
| Barinthus Biotherapeutics Pl Ads (BRNS) | 0.1 | $3.6M | 1.5M | 2.38 |
|
|
| Foghorn Therapeutics (FHTX) | 0.1 | $3.4M | 501k | 6.71 |
|
|
| Benson Hill Common Stock (BHIL) | 0.1 | $3.1M | 15M | 0.20 |
|
|
| Kronos Bio (KRON) | 0.1 | $1.9M | 1.4M | 1.30 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.8M | 641k | 2.87 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 69.06 |
|
|
| Spero Therapeutics (SPRO) | 0.1 | $1.5M | 890k | 1.72 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $1.4M | 449k | 3.11 |
|
|
| Alector (ALEC) | 0.0 | $1.1M | 176k | 6.02 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.0 | $899k | 899k | 1.00 |
|
|
| Cortexyme (QNCX) | 0.0 | $201k | 189k | 1.06 |
|
|
| Fulcrum Therapeutics (FULC) | 0.0 | $135k | 14k | 9.44 |
|
|
| Repligen Corporation (RGEN) | 0.0 | $70k | 383.00 | 183.92 |
|
|
| Mondee Holdings Class A Com (MOND) | 0.0 | $43k | 18k | 2.31 |
|
|
| Cue Health (HLTH) | 0.0 | $5.1k | 27k | 0.19 |
|
|
| Invitae (NVTAQ) | 0.0 | $0 | 236k | 0.00 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2024 Q1 filed May 3, 2024
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022
- Alphabet 2014 Q1 filed Nov. 15, 2022
- Alphabet 2014 Q2 filed Nov. 15, 2022
- Alphabet 2014 Q3 filed Nov. 15, 2022
- Alphabet 2014 Q4 filed Nov. 15, 2022
- Alphabet 2015 Q1 filed Nov. 15, 2022
- Alphabet 2015 Q2 filed Nov. 15, 2022
- Alphabet 2015 Q3 filed Nov. 15, 2022
- Alphabet 2015 Q4 filed Nov. 15, 2022